Sara C. Erickson, PharmD; Wenyi Qiu, MS; Crystal R. Maas-Patel, PharmD; Sharon M. Wang, PharmD, MS; and Bimal V. Patel, PharmD, MS
This article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.
Jan E. Berger, MD, MJ—Editor-in-Chief
There are 10 steps that need to be taken to help payers more adequately address the problem of inappropriate prescribing of pain medications.
John Smith, MD, PhD
Catherine I. Starner, PharmD, BCPS; R. Scott McClelland, PharmD; Yang Qiu, MS; Richard A. Zabinski, PharmD; Nancy Cotter, PharmD; and Patrick P. Gleason, PharmD, BCPS, FCCP
This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Myrl Weinberg, FASAE, CAE
As the administration looks at improving the insurance marketplace, patient advocates are developing a wish list of modifications to ensure that it is more patient focused.
David Calabrese, RPh, MHP; Neil B. Minkoff, MD; and Kristine Rawlings, PharmD
Pharmacosynchrony is the application of innovative clinical, analytic, and technologic pharmacy solutions to drive improved care coordination and higher-quality, more patient-centered care.
Cynthia R. Hennen, BS, RPh; and James A. Jorgenson, RPh, MS, FASHP
Successful performance of medication reconciliation can have a positive impact on patient response to a hospital stay as well as support improvement in clinical quality and financial outcome.
Megan E. Sartore, PharmD; Kimberly M. Ehman, PharmD; and Chester B. Good, MD, MPH
This study examines the results of therapeutic interventions performed by pharmacists at the Veterans Affairs Pittsburgh Healthcare System and their relevance to electronic medical records.
Tanya Burton, PhD; Ying Fan, MS; and Winghan Jacqueline Kwong, PharmD, PhD
Medications with once-daily dosing are associated with better adherence than those with twice-daily dosing. Simplifying dosing frequency provides opportunity to improve medication adherence in NVAF patients.
Rakesh Luthra, MS; Ralph Quimbo, MA; Ravi Iyer, PhD; and Michelle Luo, PhD
This retrospective study compares treatment adherence and healthcare costs for primary immunodeficiency patients receiving intravenous immunoglobulin in home and outpatient settings.